Medigus Ltd. (the “Company”), hereby announces that, following its Report of Foreign Private Issuer on Form 6-K, furnished to the Securities and Exchange Commission, or SEC, on February 13, 2020 regarding its ongoing negotiations with certain shareholders of Matomy Media Group Ltd. (“Matomy”), the Company purchased 2,284,865 ordinary shares of Matomy, representing 2.32% of the issued and outstanding share capital of Matomy for a total consideration of approximately US$ 153,034 (reflecting a price per share of NIS 0.23 (the “PPS”)). The Company continues its negotiations to purchase up to additional 22.67% of the issued and outstanding share capital of Matomy based on the same PPS.